🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, pharmacokinetics (PK),...
Status
Completed
Location
Research Facility
Start Date
2004-08
Trial ID
NCT00097747
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacodynamics (PD),...
Status
Completed
Location
Research Facilities
Start Date
2006-01
Trial ID
NCT00272662
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacodynamics (PD),...
Status
Completed
Location
Research Facility
Start Date
2005-07
Trial ID
NCT00228449
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of pegine...
Status
Completed
Location
Research Facility
Start Date
2007-10
Trial ID
NCT00597584
Treatments Being Tested
The purpose of this study is to compare the clinical safety and efficacy of...
Status
Completed
Location
Investigator
Start Date
2011-01
Trial ID
NCT01286012
The purpose of this study was to evaluate the long term safety and tolerabi...
Status
Terminated
Location
Research Facility
Start Date
2006-11
Trial ID
NCT00453973
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of pegine...
Status
Completed
Location
Research Facility
Start Date
2007-10
Trial ID
NCT00598273
Treatments Being Tested
The purpose of this study was to evaluate the safety, pharmacodynamics (PD)...
Status
Completed
Location
Research Facility
Start Date
2005-09
Trial ID
NCT00228436
Treatments Being Tested
The purpose of this study was to determine the dose ranges of peginesatide ...
Status
Completed
Location
Research Facility
Start Date
2006-12
Trial ID
NCT00434330
Treatments Being Tested
To evaluate the safety profile of single intravenous (IV) dose levels of pe...
Status
Terminated
Location
Research Facility
Start Date
2005-03
Trial ID
NCT00109291
Treatments Being Tested